false
OasisLMS
ar,zh-CN,zh-TW,en,fr,de,hi,it,ja,es,ur
Catalog
Building a Renal Denervation Program
Further Trials and Patient Preferences in RDN
Further Trials and Patient Preferences in RDN
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video transcript discusses the benefits of renal denervation therapy for patients with uncontrolled hypertension. The speaker emphasizes the need for collaborative, multidisciplinary discussions among healthcare practitioners to address the potential global public health impact of this therapy. They discuss the challenges of sustaining blood pressure control in patients long-term due to issues with medication adherence and lifestyle interventions. The speaker presents research findings from the SPIRAL program, which shows significant reductions in blood pressure with renal denervation therapy in both office and ambulatory settings. They also highlight the consistently demonstrated safety of this therapy and the potential for improved patient preference and quality of life. Ongoing studies are being conducted to further understand the benefits in specific patient populations. No credits were mentioned in the video transcript.
Asset Subtitle
David Kandzari, MD, FSCAI
Keywords
renal denervation therapy
uncontrolled hypertension
collaborative discussions
blood pressure reduction
ongoing studies
×